These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 24886334

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. An immunisation strategy for the protection of cattle against alcelaphine herpesvirus-1-induced malignant catarrhal fever.
    Haig DM, Grant D, Deane D, Campbell I, Thomson J, Jepson C, Buxton D, Russell GC.
    Vaccine; 2008 Aug 18; 26(35):4461-8. PubMed ID: 18601965
    [Abstract] [Full Text] [Related]

  • 4. The efficacy of alcelaphine herpesvirus-1 (AlHV-1) immunization with the adjuvants Emulsigen® and the monomeric TLR5 ligand FliC in zebu cattle against AlHV-1 malignant catarrhal fever induced by experimental virus challenge.
    Lankester F, Lugelo A, Werling D, Mnyambwa N, Keyyu J, Kazwala R, Grant D, Smith S, Parameswaran N, Cleaveland S, Russell G, Haig D.
    Vet Microbiol; 2016 Nov 15; 195():144-153. PubMed ID: 27771060
    [Abstract] [Full Text] [Related]

  • 5. Identification of immuno-reactive capsid proteins of malignant catarrhal fever viruses.
    Bartley K, Deane D, Percival A, Dry IR, Grant DM, Inglis NF, Mclean K, Manson ED, Imrie LH, Haig DM, Lankester F, Russell GC.
    Vet Microbiol; 2014 Sep 17; 173(1-2):17-26. PubMed ID: 25091530
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus Emulsigen are increased by formulation with CpG oligodeoxynucleotides.
    Ioannou XP, Griebel P, Hecker R, Babiuk LA, van Drunen Littel-van den Hurk S.
    J Virol; 2002 Sep 17; 76(18):9002-10. PubMed ID: 12186884
    [Abstract] [Full Text] [Related]

  • 8. Malignant catarrhal fever in American bison (Bison bison) experimentally infected with alcelaphine herpesvirus 2.
    Taus NS, O'Toole D, Herndon DR, Cunha CW, Warg JV, Seal BS, Brooking A, Li H.
    Vet Microbiol; 2014 Aug 06; 172(1-2):318-22. PubMed ID: 24803260
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Viral semaphorin inhibits dendritic cell phagocytosis and migration but is not essential for gammaherpesvirus-induced lymphoproliferation in malignant catarrhal fever.
    Myster F, Palmeira L, Sorel O, Bouillenne F, DePauw E, Schwartz-Cornil I, Vanderplasschen A, Dewals BG.
    J Virol; 2015 Apr 06; 89(7):3630-47. PubMed ID: 25589653
    [Abstract] [Full Text] [Related]

  • 12. A field vaccine trial in Tanzania demonstrates partial protection against malignant catarrhal fever in cattle.
    Lankester F, Russell GC, Lugelo A, Ndabigaye A, Mnyambwa N, Keyyu J, Kazwala R, Grant D, Percival A, Deane D, Haig DM, Cleaveland S.
    Vaccine; 2016 Feb 03; 34(6):831-8. PubMed ID: 26706270
    [Abstract] [Full Text] [Related]

  • 13. Malignant catarrhal fever-like disease in Barbary red deer (Cervus elaphus barbarus) naturally infected with a virus resembling alcelaphine herpesvirus 2.
    Klieforth R, Maalouf G, Stalis I, Terio K, Janssen D, Schrenzel M.
    J Clin Microbiol; 2002 Sep 03; 40(9):3381-90. PubMed ID: 12202582
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Unraveling clonal CD8 T cell expansion and identification of essential factors in γ-herpesvirus-induced lymphomagenesis.
    Gong M, Myster F, Azouz A, Sanchez Sanchez G, Li S, Charloteaux B, Yang B, Nichols J, Lefevre L, Javaux J, Leemans S, Nivelles O, van Campe W, Roels S, Mostin L, van den Berg T, Davison AJ, Gillet L, Connelley T, Vermijlen D, Goriely S, Vanderplasschen A, Dewals BG.
    Proc Natl Acad Sci U S A; 2024 Aug 06; 121(32):e2404536121. PubMed ID: 39088396
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. CpG-containing oligodeoxynucleotides, in combination with conventional adjuvants, enhance the magnitude and change the bias of the immune responses to a herpesvirus glycoprotein.
    Ioannou XP, Gomis SM, Karvonen B, Hecker R, Babiuk LA, van Drunen Littel-van den Hurk S.
    Vaccine; 2002 Nov 22; 21(1-2):127-37. PubMed ID: 12443671
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Stimulation of innate immune responses by CpG oligodeoxynucleotide in newborn lambs can reduce bovine herpesvirus-1 shedding.
    Nichani AK, Mena A, Kaushik RS, Mutwiri GK, Townsend HG, Hecker R, Krieg AM, Babiuk LA, Griebel PJ.
    Oligonucleotides; 2006 Nov 22; 16(1):58-67. PubMed ID: 16584295
    [Abstract] [Full Text] [Related]

  • 20. Formulation with CpG oligodeoxynucleotides prevents induction of pulmonary immunopathology following priming with formalin-inactivated or commercial killed bovine respiratory syncytial virus vaccine.
    Oumouna M, Mapletoft JW, Karvonen BC, Babiuk LA, van Drunen Littel-van den Hurk S.
    J Virol; 2005 Feb 22; 79(4):2024-32. PubMed ID: 15681404
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.